Welcome New Clinical Fellows!

Five new clinical fellows began their hematology/oncology or palliative care training programs on July 1st at Lombardi. The first year of clinical training for medical oncology and hematology Fellows is focused on an in-depth clinical experience that integrates the Fellows into the primary care of the division's patients. The faculty member shares in caring for each patient and provides year-to-year continuity in managing the patient.

Saad Jamshed, MD, (pictured at left) completed his medical degree at Dow Medical College in Karachi, Pakistan. Read more...

In the Spotlight

• Ellen McLaughlin will be repacing Dianna Edgil as Project Manager in the Lombardi administrative office.
• Summer 2006 Lombardi Magazine Now Available online and in print!
• Dr. Dritschilo announced five leadership appointments.
• Dr. Aziza Shad was appointed the US Director of the International Cancer Network.
• Dr. Robert Dickson, professor of oncology and associate director for basic science, passed away Saturday, June 24th.
• Five clinical fellows have completed their fellowship programs at Lombardi.
• Giselle Mayberry was awarded the May Lombardi Star on June 16th.
• First-Ever Cancer Vaccine Approved by FDA.
• Karen Huff, administrator for research laboratories, is retiring at the end of June. Her replacement is Deb Carbott.
• Jeff Toretsky and Aykut Uren discovered a new binding partner for EWS-FLI1, an oncoprotein associated with Ewing's sarcoma.

• Clinic Launches Lombardi Star Award to honor star employees.

Five new clinical fellows joined Lombardi in July for their 3-year fellowships.

Sean Collins, MD, PhD, joined the faculty of the cancer center on July 1st as an attending physician.

Ion Cotarla, MD, PhD, joined the Developmental Therapeutics Clinic at Lombardi as a clinical research coordinator on July 1.

More...

Newly Funded Grants

A $10.7 million DOD Center of Excellence grant was recently awarded as a multi-center grant to Fox Chase Cancer Center, Lombardi Comprehensive Cancer Center, and the Translational Genomics Research Institute.

Todd Waldman was awarded an R01 from NCI for $1.24 million to study PTEN-dependent size checkpoints in human cancers.

Chris Loffredo was awarded an R01 for $2.25 million to study gender differences in bladder cancer risk factors.

Robert Glazer received a $100,000 grant from the Charlotte Geyer Foundation and an R01 from NCI for $1.38 million.

Return to Today's Spotlight